Patent · US Active

Inhibition of nSMase for the treatment of human immunodeficiency virus infection

US11759466B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Norman Haughey · Baltimore, US
Barbara Slusher · Kingsville, US
Camilo Rojas · Baltimore, US

Key dates

Filing date	Mar 1, 2019
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Mar 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for treating a Human Immunodeficiency Virus (HIV) infection comprising administering to a subject in need of treatment thereof an effective amount of a small molecule nSMase2 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.